|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
8
|
Resverlogix Corp.
|
Dec 13, 2021 11:55AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
2
|
Resverlogix Corp.
|
Dec 13, 2021 12:46PM
|
|
Re: Courtesy
|
2
|
Resverlogix Corp.
|
Aug 19, 2017 01:17PM
|
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:36PM
|
|
Re: COVID 19 - Standard of Care
|
6
|
Resverlogix Corp.
|
Apr 22, 2021 07:51PM
|
|
Re: Covid China
|
5
|
Resverlogix Corp.
|
Mar 30, 2022 05:50PM
|
|
Re: Covid China
|
3
|
Resverlogix Corp.
|
Mar 29, 2022 10:06AM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 11:11AM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 05:27PM
|
|
Re: Covid study
|
2
|
Resverlogix Corp.
|
Feb 13, 2024 10:56AM
|
|
Re: Covid Update
|
1
|
Resverlogix Corp.
|
Jun 11, 2022 10:49AM
|
|
Re: Covid Update
|
2
|
Resverlogix Corp.
|
Jun 11, 2022 12:06PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
4
|
Resverlogix Corp.
|
Dec 14, 2021 12:30PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
7
|
Resverlogix Corp.
|
Dec 14, 2021 05:39PM
|
|
Re: CRISPR vs. BET inhibitors
|
2
|
Resverlogix Corp.
|
Jan 11, 2016 03:48PM
|
|
Re: Critique rvx-208 Science
|
3
|
Resverlogix Corp.
|
Nov 25, 2015 02:39PM
|
|
Re: CVD, kidneys, and doctors... oh my!
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 06:54PM
|
|
Re: Debenture questions.
|
3
|
Resverlogix Corp.
|
Feb 17, 2022 12:57PM
|
|
Re: Debt and 28 August
|
2
|
Resverlogix Corp.
|
Aug 02, 2017 05:34PM
|
|
Re: Dec 22
|
4
|
Resverlogix Corp.
|
Nov 10, 2020 07:02PM
|
